{"format":"alysly-page/1","url":"https://alysly.com/markets/stocks/teva-pharmaceutical-industries-limited/","json":"https://alysly.com/json/markets/stocks/teva-pharmaceutical-industries-limited/index.json","lang":"en-US","title":"Teva Pharmaceutical Industries Limited (TEVA) Stock Price Today","description":"Teva Pharmaceutical Industries Limited (TEVA). Revenue $17.3bn, net margin 8.2% (FY ended Dec 2025). ISIN IL0006290147.","modified":"2026-11-02T00:00:00Z","alternates":[{"lang":"de-DE","url":"https://alysly.com/de/maerkte/aktien/teva-pharmaceutical-industries-limited/","json":"https://alysly.com/json/de/maerkte/aktien/teva-pharmaceutical-industries-limited/index.json"}],"about":"Machine-readable version of the page at url. It contains the text, tables and key figures published there, but not the interactive charts and tools.","breadcrumb":[{"name":"Markets","url":"https://alysly.com/markets/"},{"name":"Stocks","url":"https://alysly.com/markets/stocks/"},{"name":"Teva Pharmaceutical Industries Limited","url":"https://alysly.com/markets/stocks/teva-pharmaceutical-industries-limited/"}],"content":[{"type":"heading","level":1,"text":"Teva Pharmaceutical Industries Limited (TEVA)"},{"type":"paragraph","text":"TEVA · Health Care · Israel","links":[{"text":"Health Care","href":"https://alysly.com/markets/stocks/browse/?sector=Health%20Care"},{"text":"Israel","href":"https://alysly.com/markets/stocks/browse/?country=Israel"}]},{"type":"paragraph","text":"Teva Pharmaceutical Industries Limited (TEVA) is an Israeli company in the Health Care sector. The stock has its largest weight in SPFS (MSCI World Health Care), at 0.54%. Anyone who holds an ETF containing Teva Pharmaceutical Industries Limited also has an indirect stake in the company."},{"type":"heading","level":2,"id":"data","text":"Data and Charts: Teva Pharmaceutical Industries Limited"},{"type":"heading","level":3,"text":"Key Data for Teva Pharmaceutical Industries Limited"},{"type":"facts","items":[{"label":"Held in","value":"17 ETFs"},{"label":"Highest weight","value":"0.54%"},{"label":"Indices","value":"8"},{"label":"Sector","value":"Health Care"},{"label":"Country","value":"Israel"},{"label":"ISIN","value":"IL0006290147"}]},{"type":"paragraph","text":"Data note 1","href":"#dn-1"},{"type":"heading","level":3,"text":"Teva Pharmaceutical Industries Limited Stock Price Chart"},{"type":"paragraph","text":"The Teva Pharmaceutical Industries Limited chart shows daily closing prices and is set to the current year by default. The stock is up 34.9% year to date and up 110.1% over twelve months. The last recorded close on October 30, 2026, was $42.09, at 100% of the 52-week range."},{"type":"paragraph","text":"The chart shows the US listing in US dollars. On the home exchange the price can differ, since the currency and trading hours are different. For depositary receipts (ADRs), one receipt is not always one share."},{"type":"paragraph","text":"Price series from our database since Sep 23, 2024, 529 daily values."},{"type":"paragraph","text":"Data note 2","href":"#dn-2"},{"type":"heading","level":3,"text":"Teva Pharmaceutical Industries Limited Stock Performance"},{"type":"table","caption":"Teva Pharmaceutical Industries Limited stock performance","rows":[["Year to date","+34.9%","1 year","+110.1%"],["1 month","+6.3%","3 months","+20.2%"],["Calendar year 2025","+41.6%","",""]]},{"type":"paragraph","text":"Data note 3","href":"#dn-3"},{"type":"paragraph","text":"Measured in euros, Teva Pharmaceutical Industries Limited is up 41.8% year to date and up 117.2% over twelve months. The difference from the dollar figures above comes from the exchange rate alone. Each daily price is converted at the ECB euro reference rate for that day."},{"type":"paragraph","text":"Data note 4","href":"#dn-4"},{"type":"heading","level":2,"id":"alysly","text":"Alysly Data Analysis: Teva Pharmaceutical Industries Limited"},{"type":"heading","level":3,"text":"What ETF Is Teva Pharmaceutical Industries Limited In?"},{"type":"paragraph","text":"Teva Pharmaceutical Industries Limited has above-average ETF coverage and is held by 17 of the 104 ETFs we track, which together follow 8 indices. That puts the stock in more ETFs than 77.7% of the 4,341 stocks we track.","links":[{"text":"4,341 stocks we track","href":"https://alysly.com/markets/stocks/"}]},{"type":"paragraph","text":"Data note 5","href":"#dn-5"},{"type":"table","caption":"What ETF is Teva Pharmaceutical Industries Limited in","columns":["ETF","Index","Weight","per €1,000 in the ETF"],"rows":[[{"text":"SPFS","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-health-care-ucits-etf/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.54%","€5.40"],[{"text":"XDWH","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-health-care-ucits-etf-1c/"},{"text":"MSCI World Health Care","href":"https://alysly.com/markets/indices/msci-world-health-care/"},"0.54%","€5.36"],[{"text":"XDEV","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-value-ucits-etf-1c/"},{"text":"MSCI World Value","href":"https://alysly.com/markets/indices/msci-world-value/"},"0.24%","€2.41"],[{"text":"EXUS / EXU1","links":[{"text":"EXUS","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ex-usa-ucits-etf-1c/"}]},{"text":"MSCI World ex USA","href":"https://alysly.com/markets/indices/msci-world-ex-usa/"},"0.20%","€1.96"],[{"text":"XDEM","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-momentum-ucits-etf-1c/"},{"text":"MSCI World Momentum","href":"https://alysly.com/markets/indices/msci-world-momentum/"},"0.18%","€1.77"],[{"text":"WVAL","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-value-ucits-etf-acc/"},{"text":"MSCI World Value","href":"https://alysly.com/markets/indices/msci-world-value/"},"0.16%","€1.59"],[{"text":"SWWD","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-world-ucits-etf-dist/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.06%","€0.59"],[{"text":"SPPW","href":"https://alysly.com/markets/etfs/spdr-msci-world-ucits-etf/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.06%","€0.59"],[{"text":"XDWD / XDWL","links":[{"text":"XDWD","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-ucits-etf-1c/"}]},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.05%","€0.53"],[{"text":"EUNL","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"},"0.05%","€0.50"],[{"text":"WIMI","href":"https://alysly.com/markets/etfs/xtrackers-msci-world-imi-ucits-etf-1c/"},{"text":"MSCI World IMI","href":"https://alysly.com/markets/indices/msci-world-imi/"},"0.05%","€0.47"],[{"text":"SPYY","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-ucits-etf-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.05%","€0.47"],[{"text":"SPYI / SPSA","links":[{"text":"SPYI","href":"https://alysly.com/markets/etfs/state-street-spdr-msci-all-country-world-investable-market-ucits-etf-acc/"}]},{"text":"MSCI ACWI IMI","href":"https://alysly.com/markets/indices/msci-acwi-imi/"},"0.04%","€0.42"],[{"text":"IUSQ","href":"https://alysly.com/markets/etfs/ishares-msci-acwi-ucits-etf-usd-acc/"},{"text":"MSCI ACWI","href":"https://alysly.com/markets/indices/msci-acwi/"},"0.04%","€0.40"]]},{"type":"paragraph","text":"Data note 6","href":"#dn-6"},{"type":"paragraph","text":"The last column shows how much of €1,000 in one of these funds goes to Teva Pharmaceutical Industries Limited, based on each fund's latest holdings list."},{"type":"paragraph","text":"US-listed ETFs holding Teva Pharmaceutical Industries Limited (weight per latest SEC filing): VXUS 0.09%. These funds are registered in the US; retail investors in the EU usually cannot buy them.","links":[{"text":"VXUS","href":"https://alysly.com/markets/etfs/us/vxus/"}]},{"type":"list","ordered":false,"items":[{"text":"Teva Pharmaceutical Industries Limited among the 4,341 stocks we track","href":"https://alysly.com/markets/stocks/etf-concentration/"},{"text":"Check the overlap of these 17 funds","href":"https://alysly.com/markets/etfs/overlap/"}]},{"type":"heading","level":3,"text":"Teva Pharmaceutical Industries Limited Weight in iShares Core MSCI World (EUNL) Since 2019"},{"type":"image","alt":"Teva Pharmaceutical Industries Limited: weight in EUNL 0.02% → 0.05%"},{"type":"paragraph","text":"Sep 30, 2019 Oct 30, 2026"},{"type":"paragraph","text":"In iShares Core MSCI World (EUNL), Teva Pharmaceutical Industries Limited had a weight of 0.02% on Sep 30, 2019 and 0.05% on Oct 30, 2026. The fund tracks the MSCI World. Its share peaked at 0.05% on Sep 30, 2026. The weight rises and falls with the stock's price performance relative to the other index members. It can also change when the index provider adjusts the index composition.","links":[{"text":"iShares Core MSCI World (EUNL)","href":"https://alysly.com/markets/etfs/ishares-core-msci-world-ucits-etf-usd-acc/"},{"text":"MSCI World","href":"https://alysly.com/markets/indices/msci-world/"}]},{"type":"paragraph","text":"Data note 7","href":"#dn-7"},{"type":"paragraph","text":"What's Inside Your ETF Portfolio and the ETF overlap check show how much Teva Pharmaceutical Industries Limited overlaps with the rest of a portfolio.","links":[{"text":"What's Inside Your ETF Portfolio","href":"https://alysly.com/tools/portfolio-xray/"},{"text":"ETF overlap check","href":"https://alysly.com/tools/etf-overlap/"}]},{"type":"heading","level":3,"text":"What Teva Pharmaceutical Industries Limited Executives and Directors Traded Recently"},{"type":"table","caption":"Trades by executives and directors","columns":["Date","Person","Type","Shares","Price"],"rows":[["Sep 18, 2026","Savage Brian Officer, Interim Chief Legal Officer","Sell","314","$38.70"],["Sep 18, 2026","Savage Brian Officer, Interim Chief Legal Officer","Sell","2,525","$39.15"],["Sep 18, 2026","Savage Brian Officer, Interim Chief Legal Officer","Sell","4,503","$38.69"],["Sep 18, 2026","MIGNONE ROBERTO Director","Sell","367,600","$39.06"]]},{"type":"paragraph","text":"The table shows open-market purchases and sales reported over the past 90 days. Directors, officers and shareholders owning more than ten percent must report such transactions within two trading days. Awards and option exercises are excluded."},{"type":"paragraph","text":"“Plan” means the transaction follows a schedule set up in advance under Rule 10b5-1. Sales consistently outnumber purchases in these filings because a large part of executive pay is granted in shares. For comparison: over the period covered, executives and directors reported sales at 271 of 350 tracked companies and purchases at 32."},{"type":"paragraph","text":"Data note 8","href":"#dn-8"},{"type":"heading","level":3,"text":"Stocks With ETF Exposure Similar to Teva Pharmaceutical Industries Limited"},{"type":"table","caption":"Stocks with ETF exposure similar to Teva Pharmaceutical Industries Limited","columns":["Stock","Shared ETFs","r"],"rows":[["Teva Pharmaceutical Industries Limited","–","–"],[{"text":"CSL Limited","href":"https://alysly.com/markets/stocks/csl-limited/"},"16","–"],[{"text":"Wharf Real Estate Investment Company Limited","href":"https://alysly.com/markets/stocks/wharf-real-estate-investment/"},"14","–"],[{"text":"Fisher & Paykel Healthcare Corporation Limited","href":"https://alysly.com/markets/stocks/fisher-and-paykel-healthcare/"},"14","–"],[{"text":"Woodside Energy Group","href":"https://alysly.com/markets/stocks/woodside-energy-group-ltd/"},"15","–"],[{"text":"Magna International","href":"https://alysly.com/markets/stocks/magna-international-inc/"},"15","–"],[{"text":"Wilmar International Limited","href":"https://alysly.com/markets/stocks/wilmar-international-limited/"},"15","–"],[{"text":"CK Asset Holdings Limited","href":"https://alysly.com/markets/stocks/ck-asset-holdings-limited/"},"14","–"],[{"text":"Sigma Healthcare Ltd","href":"https://alysly.com/markets/stocks/sigma-healthcare-ltd/"},"14","–"]]},{"type":"paragraph","text":"These stocks reach a portfolio through largely the same funds as Teva Pharmaceutical Industries Limited. “Shared ETFs” counts the funds that hold both."},{"type":"paragraph","text":"Data note 9","href":"#dn-9"},{"type":"heading","level":2,"id":"fundamental","text":"Fundamental Analysis: Teva Pharmaceutical Industries Limited"},{"type":"heading","level":3,"text":"Teva Pharmaceutical Industries Limited Key Financials"},{"type":"facts","items":[{"label":"Revenue","value":"$17.3B"},{"label":"Net income","value":"$1.4B"},{"label":"Diluted EPS","value":"$1.21"},{"label":"Net margin","value":"8.2%"},{"label":"Gross margin","value":"51.8%"},{"label":"Return on equity","value":"17.8%"},{"label":"Equity ratio","value":"19.4%"},{"label":"Revenue growth","value":"+4.3%"}]},{"type":"paragraph","text":"Figures come from the SEC annual filing for the latest reported fiscal year (period end Dec 31, 2025)."},{"type":"table","caption":"Revenue and profit by fiscal year","columns":["Fiscal year","Revenue","Net income","Margin"],"rows":[["FY ended Dec 2023","15.8","-0.6","-3.5%"],["FY ended Dec 2024","16.5","-1.6","-9.9%"],["FY ended Dec 2025","17.3","1.4","8.2%"]]},{"type":"paragraph","text":"Data note 10","href":"#dn-10"},{"type":"heading","level":2,"id":"technical","text":"Technical Analysis: Teva Pharmaceutical Industries Limited"},{"type":"heading","level":3,"text":"Teva Pharmaceutical Industries Limited Risk Metrics"},{"type":"facts","items":[{"label":"Max drawdown","value":"-43.7%"},{"label":"Annualized volatility","value":"43.6%"}]},{"type":"paragraph","text":"Data note 11","href":"#dn-11"},{"type":"facts","items":[{"label":"Below peak","value":"0.0%"},{"label":"Beta to S&P 500","value":"0.71"},{"label":"Correlation to S&P 500","value":"0.23"}]},{"type":"paragraph","text":"The close on Oct 30, 2026, was the highest since our series began on Sep 23, 2024. When the S&P 500 rose or fell 1%, Teva Pharmaceutical Industries Limited moved 0.71% on average in the same direction (past 252 trading days). The correlation of 0.23, however, shows only a moderate link to the broad market. Accordingly, moves in the S&P 500 explain only a small part of the daily price moves of Teva Pharmaceutical Industries Limited."},{"type":"paragraph","text":"Data note 12","href":"#dn-12"},{"type":"heading","level":3,"text":"What Teva Pharmaceutical Industries Limited Correlates With"},{"type":"table","caption":"What Teva Pharmaceutical Industries Limited Correlates With","columns":["Instrument","r","−1 … +1"],"rows":[[{"text":"Garmin Ltd.","href":"https://alysly.com/markets/stocks/garmin-ltd/"},"+0.47",""],[{"text":"GE Healthcare Technologies Inc.","href":"https://alysly.com/markets/stocks/ge-healthcare-technologies-inc/"},"+0.42",""],[{"text":"ACH","href":"https://alysly.com/markets/crypto/ach/"},"+0.42",""],[{"text":"HYPE","href":"https://alysly.com/markets/crypto/hype/"},"+0.37",""],[{"text":"Sun Communities REIT Inc.","href":"https://alysly.com/markets/stocks/sun-communities-reit-inc/"},"+0.32",""],[{"text":"SiriusXM Holdings Inc.","href":"https://alysly.com/markets/stocks/siriusxm-holdings-inc/"},"+0.32",""],[{"text":"MARSCOIN","href":"https://alysly.com/markets/crypto/marscoin/"},"-0.37",""],[{"text":"Lennox International Inc.","href":"https://alysly.com/markets/stocks/lennox-international-inc/"},"-0.35",""],[{"text":"Watsco Inc.","href":"https://alysly.com/markets/stocks/watsco-inc/"},"-0.31",""]]},{"type":"paragraph","text":"The strongest co-movers are listed at the top, the strongest inverse movers at the bottom. Low or negative correlations can help spread risk more broadly across a portfolio."},{"type":"paragraph","text":"Data note 13","href":"#dn-13"},{"type":"heading","level":2,"id":"refs","text":"Related Content: Teva Pharmaceutical Industries Limited"},{"type":"heading","level":3,"text":"Latest Investment Analysis: Stocks"},{"type":"list","ordered":false,"items":[{"text":"Oct 31, 2026 · Mixed Weekly Analysis: DAX Sets the Tone for the Week (+2.2%) · October 26–30, 2026","href":"https://alysly.com/analysis/weekly-analysis-dax-sets-tone-week-plus-2-2-percent-10312026/"},{"text":"Oct 24, 2026 · Risk-off Weekly Analysis: A Quiet Week, MSCI China -4.3% · October 19–23, 2026","href":"https://alysly.com/analysis/weekly-analysis-quiet-week-msci-china-minus-4-3-percent-10242026/"},{"text":"Oct 17, 2026 · Risk-off Weekly Analysis: S&P 500 Information Technology Weighs on the Week (-7.7%) · October 12–16, 2026","href":"https://alysly.com/analysis/weekly-analysis-sp-500-information-technology-weighs-week-10172026/"}]},{"type":"paragraph","text":"View all Investment Analysis","href":"https://alysly.com/analysis/"},{"type":"paragraph","text":"Updated Nov 2, 2026"},{"type":"heading","level":2,"id":"note-legend-h","text":"Data Notes"},{"type":"paragraph","text":"All calculations run automatically and are not investment advice."},{"type":"list","ordered":true,"items":[{"id":"dn-1","text":"Number of ETFs with available holdings data that hold the stock; the percentile compares all covered stocks against that same set."},{"id":"dn-2","text":"Price history from daily closing prices; one point per trading day."},{"id":"dn-3","text":"Returns computed automatically from the price series, excluding dividends, taxes and costs."},{"id":"dn-4","text":"Daily dollar prices converted at the same day's ECB euro reference rate, then measured like the dollar return."},{"id":"dn-5","text":"We count the funds we cover, not the market; the history covers the funds whose holdings reach back monthly."},{"id":"dn-6","text":"Holdings as of the fund's latest published holdings list; the as-of date is shown at the block."},{"id":"dn-7","text":"From the fund's published holdings lists at each quarter end, plus the latest date."},{"id":"dn-8","text":"Purchases and sales by directors, officers and ten-percent owners from Form 4 filings with the US securities regulator, reported two trading days after the transaction."},{"id":"dn-9","text":"Selected by how many of the funds we track hold both names, not by business model."},{"id":"dn-10","text":"Latest reported fiscal year from XBRL annual filings with the SEC (public domain), figures in billions of US dollars; ratios computed from them."},{"id":"dn-11","text":"Computed from the full available price history."},{"id":"dn-12","text":"From daily closes: distance from the series' highest close; beta and correlation of daily returns to the S&P 500 over the last 252 trading days."},{"id":"dn-13","text":"Co-movement of daily returns over the last 90 trading days, across asset classes."}]},{"type":"paragraph","text":"Data and methodology: Alysly · Responsible for content: Alexander Bock","links":[{"text":"Alysly","href":"https://alysly.com/methodology/"},{"text":"Alexander Bock","href":"https://alysly.com/about/"}]},{"type":"paragraph","text":"View all data notes","href":"https://alysly.com/notes/"}],"structured_data":[{"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://alysly.com/#org","name":"Alysly","url":"https://alysly.com/","logo":{"@type":"ImageObject","url":"https://alysly.com/img/icon-512.png","width":512,"height":512},"description":"Data-driven insights, transparent analysis and powerful tools for long-term investors.","email":"mail@alysly.com","contactPoint":{"@type":"ContactPoint","contactType":"customer support","email":"mail@alysly.com","availableLanguage":["de","en"]},"address":{"@type":"PostalAddress","addressLocality":"Haltern am See","postalCode":"45721","addressCountry":"DE"},"founder":{"@id":"https://alysly.com/#founder"},"sameAs":["https://www.linkedin.com/company/alyslycom/","https://www.youtube.com/@alyslycom","https://x.com/alyslycom"],"publishingPrinciples":"https://alysly.com/methodology/"},{"@type":"Person","@id":"https://alysly.com/#founder","name":"Alexander Bock","jobTitle":"Founder and data analyst","url":"https://alysly.com/about/","sameAs":["https://www.linkedin.com/in/abxk/"]},{"@type":"WebSite","@id":"https://alysly.com/#site","url":"https://alysly.com/","name":"Alysly","alternateName":"Alysly Investment Analysis","inLanguage":"en-US","publisher":{"@id":"https://alysly.com/#org"},"potentialAction":{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://alysly.com/markets/stocks/browse/?q={search_term_string}"},"query-input":"required name=search_term_string"}},{"@type":"WebPage","@id":"https://alysly.com/markets/stocks/teva-pharmaceutical-industries-limited/#webpage","url":"https://alysly.com/markets/stocks/teva-pharmaceutical-industries-limited/","name":"Teva Pharmaceutical Industries Limited – Alysly","description":"Teva Pharmaceutical Industries Limited (TEVA). Revenue $17.3bn, net margin 8.2% (FY ended Dec 2025). ISIN IL0006290147.","inLanguage":"en-US","isPartOf":{"@id":"https://alysly.com/#site"},"dateModified":"2026-11-02T00:00:00Z","publisher":{"@id":"https://alysly.com/#org"},"mainEntity":{"@id":"https://alysly.com/markets/stocks/teva-pharmaceutical-industries-limited/#entity"},"primaryImageOfPage":{"@type":"ImageObject","url":"https://alysly.com/og.png","width":1200,"height":630}}]},{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Markets","item":"https://alysly.com/markets/"},{"@type":"ListItem","position":2,"name":"Stocks","item":"https://alysly.com/markets/stocks/"},{"@type":"ListItem","position":3,"name":"Teva Pharmaceutical Industries Limited"}]},{"@context":"https://schema.org","@type":"Corporation","@id":"https://alysly.com/markets/stocks/teva-pharmaceutical-industries-limited/#entity","name":"Teva Pharmaceutical Industries Limited","tickerSymbol":"TEVA","url":"https://alysly.com/markets/stocks/teva-pharmaceutical-industries-limited/","mainEntityOfPage":"https://alysly.com/markets/stocks/teva-pharmaceutical-industries-limited/","description":"Teva Pharmaceutical Industries Limited (TEVA). Revenue $17.3bn, net margin 8.2% (FY ended Dec 2025). ISIN IL0006290147.","logo":"https://alysly.com/stock-logos/teva-pharmaceutical-industries-limited-sponsored-logo.webp","image":"https://alysly.com/stock-logos/teva-pharmaceutical-industries-limited-sponsored-logo.webp","identifier":[{"@type":"PropertyValue","propertyID":"TICKER","value":"TEVA"},{"@type":"PropertyValue","propertyID":"ISIN","value":"IL0006290147"}],"address":{"@type":"PostalAddress","addressCountry":"IL"},"subjectOf":{"@type":"Dataset","name":"Teva Pharmaceutical Industries Limited — key figures","url":"https://alysly.com/markets/stocks/teva-pharmaceutical-industries-limited/","description":"Teva Pharmaceutical Industries Limited (TEVA). Revenue $17.3bn, net margin 8.2% (FY ended Dec 2025). ISIN IL0006290147.","inLanguage":"en-US","isAccessibleForFree":true,"creator":{"@id":"https://alysly.com/#org"},"publisher":{"@id":"https://alysly.com/#org"},"variableMeasured":[{"@type":"PropertyValue","name":"Held in ETFs","value":17},{"@type":"PropertyValue","name":"Highest ETF weight (%)","value":0.5401},{"@type":"PropertyValue","name":"YTD return (%)","value":34.9},{"@type":"PropertyValue","name":"1-year return (%)","value":110.1},{"@type":"PropertyValue","name":"Sector","value":"Health Care"},{"@type":"PropertyValue","name":"Revenue (USD)","unitText":"USD","value":17258000000.0},{"@type":"PropertyValue","name":"Net income (USD)","unitText":"USD","value":1410000000.0},{"@type":"PropertyValue","name":"Total assets (USD)","unitText":"USD","value":40748000000.0},{"@type":"PropertyValue","name":"Shareholders equity (USD)","unitText":"USD","value":7910000000.0},{"@type":"PropertyValue","name":"Diluted EPS (USD)","value":1.21},{"@type":"PropertyValue","name":"Net margin (%)","value":8.200000000000001},{"@type":"PropertyValue","name":"Return on equity (%)","value":17.8},{"@type":"PropertyValue","name":"Fiscal year end","value":"2025-12-31"}],"temporalCoverage":"2024-09-23/.."}}],"notice":"© 2026 Alysly.com. Not investment advice. All data without guarantee. Financial information is analyzed and presented partly with AI assistance."}